Crinetics Pharmaceuticals IncNASDAQ:CRNX
- LAST PRICE44.7100
- TODAY'S CHANGE (%)-1.1300 (-2.4651%)
- Bid / Lots38.0000/ 1
- Ask / Lots44.7000/ 1
- Open / Previous Close45.3300 / 45.8400
- Day Range
- 52 Week Range
- Volume486,753
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRNX |
|---|---|---|
| 09:32 ET | 3665 | 45.36 |
| 09:36 ET | 610 | 45.04 |
| 09:38 ET | 1905 | 44.99 |
| 09:39 ET | 1300 | 45.3 |
| 09:43 ET | 2500 | 45.36 |
| 09:45 ET | 700 | 45.4501 |
| 09:48 ET | 900 | 45.51 |
| 09:54 ET | 100 | 45.31 |
| 10:01 ET | 900 | 45.56 |
| 10:03 ET | 5466 | 46.06 |
| 10:06 ET | 1000 | 46.06 |
| 10:08 ET | 200 | 46.4199 |
| 10:10 ET | 300 | 46.405 |
| 10:12 ET | 1927 | 46.33 |
| 10:14 ET | 300 | 46.38 |
| 10:15 ET | 800 | 46.59 |
| 10:17 ET | 1100 | 46.415 |
| 10:19 ET | 100 | 46.425 |
| 10:21 ET | 720 | 46.13 |
| 10:24 ET | 2010 | 46.4 |
| 10:26 ET | 100 | 46.455 |
| 10:28 ET | 100 | 46.46 |
| 10:30 ET | 100 | 46.46 |
| 10:32 ET | 2598 | 46.31 |
| 10:33 ET | 200 | 46.18 |
| 10:35 ET | 700 | 46.23 |
| 10:42 ET | 1000 | 46.145 |
| 10:44 ET | 900 | 46.12 |
| 10:46 ET | 100 | 46.08 |
| 10:48 ET | 4406 | 46.325 |
| 10:50 ET | 800 | 46.37 |
| 10:51 ET | 200 | 46.375 |
| 10:53 ET | 2944 | 46.355 |
| 10:55 ET | 1300 | 46.355 |
| 10:57 ET | 8872 | 46.355 |
| 11:00 ET | 1700 | 46.345 |
| 11:02 ET | 3737 | 46.27 |
| 11:06 ET | 2060 | 45.99 |
| 11:08 ET | 100 | 45.835 |
| 11:09 ET | 500 | 45.805 |
| 11:11 ET | 5275 | 45.72 |
| 11:13 ET | 500 | 45.69 |
| 11:15 ET | 504 | 45.68 |
| 11:18 ET | 100 | 45.63 |
| 11:20 ET | 600 | 45.59 |
| 11:22 ET | 300 | 45.52 |
| 11:24 ET | 1148 | 45.685 |
| 11:27 ET | 300 | 45.6 |
| 11:29 ET | 988 | 45.53 |
| 11:31 ET | 929 | 45.4812 |
| 11:38 ET | 100 | 45.49 |
| 11:40 ET | 13447 | 45.44 |
| 11:42 ET | 200 | 45.5 |
| 11:44 ET | 500 | 45.41 |
| 11:45 ET | 400 | 45.32 |
| 11:47 ET | 100 | 45.33 |
| 11:51 ET | 600 | 45.375 |
| 11:54 ET | 100 | 45.36 |
| 11:56 ET | 500 | 45.365 |
| 11:58 ET | 300 | 45.355 |
| 12:00 ET | 300 | 45.335 |
| 12:02 ET | 1450 | 45.23 |
| 12:03 ET | 193 | 45.22 |
| 12:05 ET | 450 | 45.1594 |
| 12:07 ET | 200 | 45.14 |
| 12:09 ET | 200 | 45.14 |
| 12:12 ET | 200 | 45.17 |
| 12:14 ET | 100 | 45.11 |
| 12:16 ET | 200 | 45.13 |
| 12:18 ET | 573 | 45.12 |
| 12:20 ET | 1400 | 45.3 |
| 12:23 ET | 100 | 45.21 |
| 12:25 ET | 100 | 45.2 |
| 12:27 ET | 2175 | 45.27 |
| 12:30 ET | 3100 | 45.26 |
| 12:32 ET | 100 | 45.345 |
| 12:34 ET | 421 | 45.335 |
| 12:36 ET | 100 | 45.34 |
| 12:38 ET | 200 | 45.31 |
| 12:39 ET | 100 | 45.25 |
| 12:41 ET | 500 | 45.24 |
| 12:43 ET | 100 | 45.23 |
| 12:50 ET | 1450 | 45.175 |
| 12:52 ET | 930 | 45.17 |
| 12:54 ET | 1300 | 45.185 |
| 12:56 ET | 3146 | 45.13 |
| 12:57 ET | 13342 | 45.18 |
| 12:59 ET | 400 | 45.14 |
| 01:01 ET | 700 | 45.11 |
| 01:03 ET | 600 | 45.12 |
| 01:06 ET | 1668 | 45.14 |
| 01:08 ET | 223 | 45.13 |
| 01:10 ET | 1163 | 45.0971 |
| 01:12 ET | 3699 | 45.05 |
| 01:14 ET | 2073 | 45.16 |
| 01:15 ET | 800 | 45.1833 |
| 01:17 ET | 800 | 45.32 |
| 01:19 ET | 100 | 45.33 |
| 01:24 ET | 100 | 45.31 |
| 01:28 ET | 500 | 45.17 |
| 01:30 ET | 200 | 45.1 |
| 01:32 ET | 100 | 45.105 |
| 01:33 ET | 100 | 45.14 |
| 01:35 ET | 200 | 45.11 |
| 01:37 ET | 981 | 45.08 |
| 01:39 ET | 527 | 45.16 |
| 01:42 ET | 100 | 45.12 |
| 01:48 ET | 200 | 45.14 |
| 01:50 ET | 200 | 45.11 |
| 01:51 ET | 100 | 45.08 |
| 01:53 ET | 1250 | 45.166 |
| 02:00 ET | 700 | 45.12 |
| 02:02 ET | 1309 | 44.99 |
| 02:04 ET | 100 | 45 |
| 02:06 ET | 400 | 44.98 |
| 02:08 ET | 100 | 44.97 |
| 02:09 ET | 400 | 44.905 |
| 02:11 ET | 1603 | 45.01 |
| 02:13 ET | 200 | 45.01 |
| 02:15 ET | 400 | 44.96 |
| 02:18 ET | 112 | 44.945 |
| 02:22 ET | 829 | 44.99 |
| 02:26 ET | 100 | 44.95 |
| 02:27 ET | 300 | 45.02 |
| 02:29 ET | 500 | 44.97 |
| 02:31 ET | 3905 | 44.9 |
| 02:33 ET | 1355 | 44.99 |
| 02:36 ET | 400 | 44.985 |
| 02:40 ET | 500 | 44.99 |
| 02:42 ET | 516 | 44.995 |
| 02:44 ET | 600 | 45.04 |
| 02:45 ET | 395 | 45.04 |
| 02:47 ET | 228 | 45.045 |
| 02:51 ET | 500 | 44.96 |
| 02:56 ET | 2300 | 44.96 |
| 02:58 ET | 300 | 44.955 |
| 03:00 ET | 100 | 44.94 |
| 03:02 ET | 1000 | 44.9 |
| 03:03 ET | 483 | 44.94 |
| 03:05 ET | 5571 | 44.95 |
| 03:07 ET | 700 | 44.91 |
| 03:09 ET | 810 | 44.91 |
| 03:12 ET | 800 | 44.87 |
| 03:14 ET | 5285 | 44.77 |
| 03:16 ET | 8282 | 44.88 |
| 03:18 ET | 2600 | 44.95 |
| 03:20 ET | 10543 | 44.92 |
| 03:21 ET | 1496 | 44.94 |
| 03:23 ET | 100 | 44.97 |
| 03:25 ET | 5094 | 45.03 |
| 03:27 ET | 1512 | 45.08 |
| 03:30 ET | 300 | 45.02 |
| 03:32 ET | 2960 | 45.02 |
| 03:34 ET | 2627 | 45.12 |
| 03:36 ET | 1396 | 45.09 |
| 03:38 ET | 925 | 44.99 |
| 03:39 ET | 4604 | 45.09 |
| 03:41 ET | 4087 | 45.12 |
| 03:43 ET | 1158 | 45.04 |
| 03:45 ET | 1134 | 45 |
| 03:48 ET | 4685 | 44.99 |
| 03:50 ET | 3409 | 44.935 |
| 03:52 ET | 1818 | 44.92 |
| 03:54 ET | 2822 | 44.8 |
| 03:56 ET | 5749 | 44.84 |
| 03:57 ET | 5536 | 44.79 |
| 03:59 ET | 11977 | 44.71 |
Jun 4, 2024
DJ Crinetics Pharmaceuticals Price Target Maintained With a $80.00/Share by JMP Securities, from 8:29AM ET on Tuesday Jun 04, 2024 by Dow Jones
8:29AM ET on Tuesday Jun 04, 2024 by Dow JonesDJ Crinetics Pharmaceuticals Is Maintained at Outperform by Oppenheimer, from 8:19AM ET on Tuesday Jun 04, 2024 by Dow Jones
8:19AM ET on Tuesday Jun 04, 2024 by Dow JonesDJ Crinetics Pharmaceuticals Price Target Maintained With a $60.00/Share by HC Wainwright & Co., from 7:37AM ET on Tuesday Jun 04, 2024 by Dow Jones
7:37AM ET on Tuesday Jun 04, 2024 by Dow Jones
Jun 3, 2024
Crinetics Presents New Data at ENDO 2024 that Increases Body of Evidence Positioning Once-Daily, Oral Paltusotine as Potential First-Choice Treatment Option for Acromegaly, from 12:00PM ET on Monday Jun 03, 2024 by Dow Jones
12:00PM ET on Monday Jun 03, 2024 by Dow JonesCrinetics Announces Positive Initial Findings at ENDO 2024 for Atumelnant in Two Ongoing, Open-Label Studies for the Treatment of Congenital Adrenal Hyperplasia (CAH) and ACTH-Dependent Cushing's Syndrome (ADCS), from 12:00PM ET on Monday Jun 03, 2024 by Dow Jones
12:00PM ET on Monday Jun 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Crinetics Pharmaceuticals Inc | 3.7B | -11.9x | --- |
Immunovant Inc | 3.7B | -13.3x | --- |
Immunitybio Inc | 4.3B | -5.8x | --- |
Merus NV | 3.4B | -19.4x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Dyne Therapeutics Inc | 3.1B | -7.8x | --- |
Company Information
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Contact Information
- Headquarters
- 10222 Barnes Canyon Rd Bldg 2SAN DIEGO, CA, United States 92121-2711
- Phone
- 858-450-6464
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Wendell Wierenga
- Co-Founder, Director
- R. Scott Struthers
- Co-Founder, Chief Scientific Officer
- Stephen Betz
- Chief Financial Officer
- Marc Wilson
- Chief Operating Officer
- Jeff Knight
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.7B |
|---|---|
Revenue (TTM) | $2.0M |
Shares Outstanding | 78.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.68 |
EPS | $-3.77 |
Book Value | $7.91 |
P/E Ratio | -11.9x |
Price/Sales (TTM) | 1,890.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -12,571.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
